Find clinical trials for Lymphoma in Hanyang, Seoul
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Lymphoma trials near Hanyang, Seoul, KOR:
The purpose of this study is to evaluate the safety, tolerability, and preliminary efficacy of CC-99282 alone and in combination with anti-lymphoma...
Phase 1, Phase 2
Seoul, Korea, Republic of and 68 other locations
1 and Phase 2 components in subjects with advanced solid tumors and lymphoma who have progressed despite having standard therapy or for whic...
Phase 1, Phase 2
Seoul, Korea, Republic of and 3 other locations
on participants who have one of two types of cancer: follicular lymphoma (FL) or marginal zone lymphoma (MZL) that has come back af...
Phase 3
Seoul, South Korea and 152 other locations
The primary objective of this study is to determine the recommended dosing regimen of loncastuximab tesirine in diffuse large B-cell lymphoma...
Phase 1
Seoul, Seoul Teugbyeolsi, Korea, Republic of and 13 other locations
This study will characterize the safety and clinical benefit of valemetostat tosylate in participants with relapsed/refractory peripheral T-cell lymphoma...
Phase 2
Seoul, Seoul Teugbyeolsi, Korea, Republic of and 59 other locations
treatment of advanced classical Hodgkin lymphoma(HL)...
Phase 3
Seoul, Korea, Republic of and 215 other locations
This study was conducted to evaluate the 2-year progression free survival rate of elderly patients with primary CNS lymphoma followed by com...
Phase 2
Seoul, Gangnam-gu,, Korea, Republic of
to assess the efficacy and safety of golcadomide in combination with rituximab in participants with newly diagnosed advanced stage Follicular Lymphoma...
Phase 2
Seoul, Seoul-teukbyeolsi [Seoul], Korea, Republic of and 67 other locations
pharmacokinetics, pharmacodynamics, and anti-tumor activity of DR-0201 in adult patients with relapsed or refractory B-cell non-Hodgkin lymphoma...
Phase 1
Seoul, Korea, Republic of and 20 other locations
choice in participants with relapsed/refractory follicular lymphoma who have received at least one line of prior systemic therapy....
Phase 3
Seoul, Seoul-teukbyeolsi [Seoul], South Korea and 153 other locations
Clinical trials
Research sites
Resources
Legal